Holen Sie sich die Stockscreener-App
552.41
0.40%
2.22
Vorhandelsmarkt:
560.15
7.74
+1.40%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$550.19
Offen:
$550.51
24-Stunden-Volumen:
1.01M
Relative Volume:
0.47
Marktkapitalisierung:
$197.99B
Einnahmen:
$8.71B
Nettoeinkommen (Verlust:
$2.48B
KGV:
81.00
EPS:
6.82
Netto-Cashflow:
$1.75B
1W Leistung:
+0.98%
1M Leistung:
+7.47%
6M Leistung:
+2.57%
1J Leistung:
+37.75%
1-Tages-Spanne:
$549.43
$556.16
1-Wochen-Bereich:
$529.15
$556.16
52-Wochen-Spanne:
$396.15
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
552.41 | 196.08B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
173.01 | 49.62B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.38 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.76 | 36.04B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
80.12 | 15.87B | 3.93B | 415.40M | 384.70M | 2.06 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Intuitive Surgical Stock: Moat, Resilience But High Market Expectations (NASDAQ:ISRG) - Seeking Alpha
Intuitive Surgical (NASDAQ:ISRG): Strongest Q1 Results from the Surgical Equipment & ConsumablesSpecialty Group - Yahoo Finance
Prostate Biopsies Device Market May See a Big Move | Major Giants- Medtronic, Intuitive Surgical, Hologic - openPR.com
30 years of Innovation and Impact: Dan Larson's Inspiring Story - GlobeNewswire
Intuitive Celebrates 30 Years of Innovation in Robotic-Assisted Surgery with Patient Success Story from Lung Cancer Survivor Dan Larson - Nasdaq
From Boeing Engineer to Cancer Survivor: How Intuitive's Robotic Surgery Changed One Man's Life - Stock Titan
Intuitive Surgical: The Business Model Of Robotic Surgery Supports A Bullish Outlook - Seeking Alpha
Navigated Surgical Robot Market Outlook and Future Projections for 2030 - openPR.com
Minimally Invasive Surgical Robot System Market Outlook and Future Projections for 2030 - openPR.com
Hong Kong surgical robot start-up Cornerstone takes aim at da Vinci - South China Morning Post
Autonomous Surgical Robotics Market Outlook and Future Projections for 2030 - openPR.com
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.58%: What You Should Know - MSN
Insights into the Robotic Patient Care Solutions Market 2025: - openPR.com
Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.
Citigroup Raises Price Target on ISRG to $650, Maintains Buy Rat - GuruFocus
Citi Boosts Price Target for Intuitive Surgical (ISRG) to $650 | ISRG Stock News - GuruFocus
Citigroup Adjusts Price Target on Intuitive Surgical to $650 From $590, Maintains Buy Rating - marketscreener.com
2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold - The Motley Fool
Surgical Robot Maker to Become City’s Biggest Employer with $540M Campus Expansion - Peachtree Corners Magazine
$1000 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today - Benzinga
Do Wall Street Analysts Like Intuitive Surgical Stock? - MSN
The End of an Era: Intuitive Surgical Names New CEO - Medical Device and Diagnostic industry
How to Take Advantage of moves in (ISRG) - news.stocktradersdaily.com
Spinal Surgical Robots Market Is Going to Boom | Major Giants Medtronic, Renishaw, Orthofix Medical - openPR.com
Medical Technology Company Intuitive Expanding in Peachtree Corners, Adding Approximately 1,200 New Jobs - Peachtree Corners Magazine
Olympus Hires Former Intuitive VP Slawek Kierner as Chief Digital Officer - Medical Product Outsourcing
Intuitive Surgical (ISRG) Sees Surge in Bullish Options Activity - GuruFocus
Robot-assisted Surgery Market Is Booming Worldwide 2025-2032 | - openPR.com
Olympus adds former Intuitive digital leader as chief digital officer - MassDevice
Medical Robots Market 2025-2032: Top Trends & Growth Drivers | - openPR.com
A human touch: WinnMed eyeing purchase of modern surgical robot - Decorah Leader
Intuitive Surgical Slips After CEO Gary Guthart Unexpectedly Steps Down - MSN
Intuitive Surgical (NasdaqGS:ISRG) Announces Leadership Transition With Dave Rosa as New CEO - simplywall.st
Baird says CEO ‘well-equipped’ to further Intuitive Surgical position - Yahoo Finance
With Competition Rising, Should Investors Give Up On This Top Growth Stock? - AOL.com
Bank of America Securities Sticks to Its Buy Rating for Intuitive Surgical (ISRG) - The Globe and Mail
Intuitive names Dave Rosa as new CEO starting July 1 By Investing.com - Investing.com Nigeria
Intuitive Surgical (ISRG) Announces Executive Leadership Changes - GuruFocus
Robotic Surgery Titan Dips On Surprise CEO Transition - Investor's Business Daily
Intuitive Announces Board Changes, Effective July 1, 2025 - marketscreener.com
What's Going On With Intuitive Surgical Stock On Thursday? - Benzinga
Intuitive Surgical (ISRG) Appoints Dave Rosa as New CEO | ISRG S - GuruFocus
Intuitive Announces CEO Transition Effective July 1, 2025 | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Appoints Dave Rosa as New CEO | ISRG Stock News - GuruFocus
Intuitive CEO Gary Guthart to step down after 15 years - MedTech Dive
Intuitive Surgical promotes Dave Rosa to CEO - Modern Healthcare
Intuitive Surgical (ISRG) Announces Leadership Transition | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Names Dave Rosa as Next CEO - GuruFocus
Intuitive Promotes President Dave Rosa to CEO - Medical Product Outsourcing
Intuitive Surgical is making a CEO change - MassDevice
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):